Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Quarterly profit growth exceeded sales growth, while the annual outlook moved higher.
Directly affected
- AMGN Amgen+13.5% 30d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF+0.1% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- QQQ Invesco QQQ-9.8% 30d
Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Amgen belongs to, so it often moves with news about it.
- GILD Gilead Sciences+13.4% 30d
Gilead Sciences is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+25.4% 30d
Moderna is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-16.8% 15d
argenx SE is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- BIIB Biogen+15.3% 19d
Biogen is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AMGN | -2.03% | +1.07% | base | +3.67% | after close | after close | after close |
| DIA | +1.47% | -0.00% | base | +3.10% | after close | after close | after close |
| QQQ | +5.88% | +0.76% | base | +0.93% | after close | after close | after close |
| XLV | -2.31% | +0.48% | base | +3.08% | after close | after close | after close |
| GILD | -4.93% | +2.07% | base | +4.16% | after close | after close | after close |
| MRNA | -6.29% | -2.97% | base | +13.13% | after close | after close | after close |
| ARGX | -1.09% | -0.93% | base | +3.36% | after close | after close | after close |
| RVMD | -2.84% | -1.45% | base | +2.75% | after close | after close | after close |
| BIIB | -1.90% | +1.86% | base | +2.22% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test Yahoo Finance
Source: Yahoo Finance
How far Spdr Dow Jones Industrial Average Etf Trust (DIA) has moved since 4 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | +3.67% | final price |
| AMGN | three days earlier | +1.07% | final price |
| AMGN | five days earlier | -2.03% | final price |
| ARGX | that day | +3.36% | final price |
| ARGX | three days earlier | -0.93% | final price |
| ARGX | five days earlier | -1.09% | final price |
| BIIB | that day | +2.22% | final price |
| BIIB | three days earlier | +1.86% | final price |
| BIIB | five days earlier | -1.90% | final price |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | that day | +3.10% | final price |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | three days earlier | -0.00% | final price |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | five days earlier | +1.47% | final price |
| GILD | that day | +4.16% | final price |
| GILD | three days earlier | +2.07% | final price |
| GILD | five days earlier | -4.93% | final price |
| MRNA | that day | +13.13% | final price |
| MRNA | three days earlier | -2.97% | final price |
| MRNA | five days earlier | -6.29% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | that day | +0.93% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | +0.76% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | +5.88% | final price |
| RVMD | that day | +2.75% | final price |
| RVMD | three days earlier | -1.45% | final price |
| RVMD | five days earlier | -2.84% | final price |
| XLV | that day | +3.08% | final price |
| XLV | three days earlier | +0.48% | final price |
| XLV | five days earlier | -2.31% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 43 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 70 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 84 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 86 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 68 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Biogen (BIIB), worth $1,001 - $15,000 on 24 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Biogen (BIIB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Biogen (BIIB), worth $1,001 - $15,000 on 18 Aug 2026. That is 78 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Spdr Dow Jones Industrial Average Etf Trust (DIA)
Companies mentioned with this story
- DIA Spdr Dow Jones Industrial Average Etf Trust
In “Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test,” Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence. Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- QQQ Invesco Qqq Trust, Series 1
In “Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test,” Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence. Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- IWM Ishares Tr
For “Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test,” Ishares Tr (IWM) is linked, with no stored direction, medium confidence. Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- RSP Invesco Exchange Traded Fd T
For “Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- VTI Vanguard Index Fds
Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test.” Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Spdr Dow Jones Industrial Average Etf Trust (DIA)
On 4 Nov 2026, “Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test” is the story that connects Spdr Dow Jones Industrial Average Etf Trust (DIA) to this story.
What ties Spdr Dow Jones Industrial Average Etf Trust (DIA) to the headline is this: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Also listed, Invesco Qqq Trust, Series 1 (QQQ): Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Dates and price levels for Spdr Dow Jones Industrial Average Etf Trust (DIA)
DIA traded between 504.92 and 522.62 across 18 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 285.25 across 20 sessions. The latest close on file is 279.20. QQQ traded between 680.34 and 757.18 across 20 sessions. The latest close on file is 685.32.
A simple score for Spdr Dow Jones Industrial Average Etf Trust (DIA)
40 out of 100
“Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test” scores 40 out of 100. The score uses 1 sources, and 5 linked companies.